Lactated Ringer's Injection USP
Lack of assurance of sterility: bags have the potential to leak..
Every FDA drug recall initiated in 2024, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
557 recalls, newest first.
Lack of assurance of sterility: bags have the potential to leak..
Superpotent Drug: Due to overfilling of drug powder
Subpotent Drug
cGMP Diviations
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
CGMP Deviations
The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.
Failed Dissolution Specifications
Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.
Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
Presence of Particulate Matter.
Cross Contamination with Other Products:(mycophenolate mofetil).
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Failed Stability Specifications